Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study

Overview of attention for article published in European Urology, September 2025

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,208 followers.

RT @dralvaropinto: Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the…

Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study - European Urology https://t.co/vBInAeYFGJ

Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study -@EUplatinum https://t.co/2fKmKOOz69

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.